ViaCyte, Inc., formerly Novocell, Inc., is a stem cell engineering company dedicated to creating, delivering and commercializing cell and drug therapies to treat diabetes and other chronic diseases. The company was founded in 1999 and merged with CyThera and Bresagen in 2004.